In this 10 year follow-up of a representative cohort of older people with type 2 diabetes, higher baseline levels of systemic inflammatory markers, including plasma IL-6 and fibrinogen, predicted greater cognitive decline. This evidence concerns the gene IL6 and type 2 diabetes mellitus.